Shire Pharmaceuticals Group plc Closing Owings Mills Plant to Focus on New Drug Deals; Company to Layoff 260 Workers Over Next Three Years

Baltimore Sun -- Biopharmaceutical company Shire plans to close its Owings Mills plant in phases over three years and lay off 260 workers as it discontinues in-house manufacturing of drugs to treat attention-deficit and hyperactivity disorders and gastrointestinal diseases, a company spokesman said Thursday.

Back to news